Companies/Securities in Focus
PR9 : PRARAM 9 HOSPITAL PUBLIC COMPANY LIMITED
| Accounting Type | Company |
| Status | Audited |
| Period | Year Ended 2021 |
 |
Latest Financial Statement |
| Net Cash From Operating Activities(Unit: M.Baht) | |
| Net Profit (Loss) Attributable To Owners Of The Parent For The Period | 300.27 |
| Depreciation And Amortisation | 293.72 |
| (Reversal Of) Expected Credit Losses | 17.60 |
| (Gains) Losses On Fair Value Adjustments Of Investments | -0.29 |
| (Gains) Losses On Disposal And Write-Off Of Fixed Assets | 0.64 |
| Dividend And Interest Income | -4.21 |
| Interest Income | -4.21 |
| Finance Costs | 0.48 |
| Employee Benefit Expenses | 16.47 |
| Cash Flows From (Used In) Operations Before Changes In Operating Assets And Liabilities | 624.66 |
| (Increase) Decrease In Operating Assets | |
| (Increase) Decrease In Trade And Other Receivables | -70.91 |
| (Increase) Decrease In Inventories | -6.85 |
| (Increase) Decrease In Other Operating Assets | -83.88 |
| Increase (Decrease) In Operating Liabilities | |
| Increase (Decrease) In Trade And Other Payables | 168.01 |
| Increase (Decrease) In Provisions For Employee Benefit Obligations | -8.85 |
| Increase (Decrease) In Other Operating Liabilities | 5.70 |
| Cash Generated From (Used In) Operations | 627.88 |
| Income Tax (Paid) Received | -39.86 |
| Net Cash From (Used In) Operating Activities | 588.02 |
| Net Cash From Investing Activities(Unit: M.Baht) | |
| (Increase) Decrease In Short-Term Investments | -52.22 |
| Proceeds From Investment | 0.01 |
| Proceeds From Redemption Of Debt Securities | 0.01 |
| Purchase Of Investments | -100.00 |
| Proceeds From Disposal Of Fixed Assets | 1.92 |
| Payment For Purchase Of Fixed Assets** | -252.70 |
| Intangible Assets | -8.88 |
| Interest Received | 4.14 |
| Net Cash From (Used In) Investing Activities | -398.86 |
| Net Cash From Financing Activities(Unit: M.Baht) | |
| Repayments On Lease Liabilities | -5.08 |
| Dividend Paid | -86.17 |
| Net Cash From (Used In) Financing Activities | -91.26 |
| Net Increase (Decrease) In Cash And Cash Equivalent | 97.91 |
| Cash And Cash Equivalents, Beginning Balance | 592.47 |
| Cash And Cash Equivalents, Ending Balance | 690.38 |
Remark
** A main item may not be equal to an aggregation from sub items due to an additional amount which cannot be included in sub items. For foreign listed company (Secondary Listing), financial statement data follows the standards of the home exchange.
** A main item may not be equal to an aggregation from sub items due to an additional amount which cannot be included in sub items. For foreign listed company (Secondary Listing), financial statement data follows the standards of the home exchange.
